• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Rho GTPase-activating protein 5 (ARHGAP5), Truncated

ACP17885

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP17885 Target NameARHGAP5
Target SynonymsArhgap5; p190-B; RHG05_HUMAN; Rho GTPase activating protein 5; Rho GTPase-activating protein 5; Rho-type GTPase-activating protein 5FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Protein LengthPartial
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ13017
Background Information
  • Uniprot Id

    Q13017

  • Target Species

    Human

  • Target Name

    ARHGAP5

  • Target Full Name

    Rho GTPase-activating protein 5

  • Target Function

    GTPase-activating protein for Rho family members.

  • Target Subcellular Location

    Cytoplasm. Cell membrane; Peripheral membrane protein.

  • Target Tissue Specificity

    Detected in skin fibroblasts (at protein level).

  • Target Synonyms

    Arhgap5; p190-B; RHG05_HUMAN; Rho GTPase activating protein 5; Rho GTPase-activating protein 5; Rho-type GTPase-activating protein 5

  • Target Background

    Rho GTPase activating protein 5 negatively regulates RHO GTPases, a family which may mediate cytoskeleton changes by stimulating the hydrolysis of bound GTP. Two transcript variants encoding different isoforms have been found for this gene.

Inquire Recombinant Human Rho GTPase-activating protein 5 (ARHGAP5), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification